Work

Management of multiple myeloma during COVID-19 pandemic

Year: 2020

Type: article

Abstract: At the end of 2019, a novel coronavirus was identified as the cause of pneumonia cases in Wuhan, a city in the Hubei Province of China. On January 30, 2020, the World Health Organization (WHO) declared the COVID-19 outbreak a public health emergency of international concern and, in March 2020, began to characterize it as a pandemic. The virus that causes COVID-19 is designated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) In February 2020, the World Health Organization designated the disease COVID-19, which stands for coronavirus disease 2019.

Source: Leukemia Research Reports

DOI: 10.1016/j.lrr.2020.100212

Authors: YS Jethava, Rafael Fonseca, Ola Landgren

Institutions: University of Iowa Hospitals and Clinics, Mayo Clinic Comprehensive Cancer Center (Arizona), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $650